1. Home
  2. SEPN vs SLSR Comparison

SEPN vs SLSR Comparison

Compare SEPN & SLSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • SLSR
  • Stock Information
  • Founded
  • SEPN 2022
  • SLSR 2018
  • Country
  • SEPN United States
  • SLSR Canada
  • Employees
  • SEPN N/A
  • SLSR N/A
  • Industry
  • SEPN
  • SLSR
  • Sector
  • SEPN
  • SLSR
  • Exchange
  • SEPN NYSE
  • SLSR NYSE
  • Market Cap
  • SEPN 631.0M
  • SLSR 539.0M
  • IPO Year
  • SEPN 2024
  • SLSR N/A
  • Fundamental
  • Price
  • SEPN $5.70
  • SLSR $3.33
  • Analyst Decision
  • SEPN Buy
  • SLSR Buy
  • Analyst Count
  • SEPN 4
  • SLSR 2
  • Target Price
  • SEPN $33.00
  • SLSR $10.00
  • AVG Volume (30 Days)
  • SEPN 420.0K
  • SLSR 46.6K
  • Earning Date
  • SEPN 03-27-2025
  • SLSR 03-20-2025
  • Dividend Yield
  • SEPN N/A
  • SLSR N/A
  • EPS Growth
  • SEPN N/A
  • SLSR N/A
  • EPS
  • SEPN N/A
  • SLSR N/A
  • Revenue
  • SEPN $1,075,000.00
  • SLSR N/A
  • Revenue This Year
  • SEPN N/A
  • SLSR N/A
  • Revenue Next Year
  • SEPN N/A
  • SLSR N/A
  • P/E Ratio
  • SEPN N/A
  • SLSR N/A
  • Revenue Growth
  • SEPN 611.92
  • SLSR N/A
  • 52 Week Low
  • SEPN $4.17
  • SLSR $2.88
  • 52 Week High
  • SEPN $28.99
  • SLSR $3.76
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • SLSR 46.02
  • Support Level
  • SEPN N/A
  • SLSR $3.43
  • Resistance Level
  • SEPN N/A
  • SLSR $3.69
  • Average True Range (ATR)
  • SEPN 0.00
  • SLSR 0.16
  • MACD
  • SEPN 0.00
  • SLSR 0.00
  • Stochastic Oscillator
  • SEPN 0.00
  • SLSR 52.67

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About SLSR SOLARIS RESOURCES INC

Solaris Resources Inc is advancing a portfolio of copper and gold assets in the Americas, which includes a high-grade resource with expansion and additional discovery potential at the Warintza copper and gold project in Ecuador; discovery potential on the grass-roots Tamarugo project in Chile and Capricho and Paco Orco projects in Peru, and the La Verde joint venture project.

Share on Social Networks: